Adults receiving tirzepatide in the SURPASS trials had ... SURPASS trials enrolled adults with type 2 diabetes or overweight or obesity and without contraindications for GIP/GLP-1 use.

today announced the completion of its Phase 2 BMT-801 clinical study of the co-administration of MC4R bremelanotide + GLP-1/GIP tirzepatide for the treatment of obesity. The last patient enrolled ...

The Eastwoods are continuing to focus on the positive. "He's good," Scott told People in an interview published Jan. 17. "He's doing good. He's a survivor, a trouper." The 38-year-old explained ...

Weight loss drugs like Ozempic and wegovy have become global sensation. In the recent years, companies like Novo Nordisk and Eli Lilly have GLP-1 agonists and dual GLP-1/GIP receptor agonists that ...

on Thursday announced the completion of its Phase 2 BMT-801 clinical study evaluating the combination of MC4R bremelanotide and GLP-1/GIP tirzepatide for the treatment of obesity. The study ...

Eli Lilly has invested heavily into obesity, dominating the landscape—alongside semaglutide maker Novo Nordisk—with its blockbuster molecule tirzepatide. Now, with a pipeline chock-full of ...

Adam Scott returns in the award-winning drama, Severance. Back for a second season, the actor reprises his role as Mark S, a macrodata refiner working at Lumon Industries. To say his character's ...

Prescriptions of obesity management drugs (OMDs ... semaglutide (Wegovy), liraglutide (Saxenda), and tirzepatide (Zepbound). By February 2024, phentermine, Wegovy, and Zepbound had about 0. ...

The researchers found that 69,213,936 prescriptions for OMDs were dispensed in the United States during the study period, (HealthDay News) — Prescriptions of obesity management drugs (OMDs ...

At least nine patients using the glucagon-like peptide 1 (GLP-1) receptor agonists semaglutide and tirzepatide developed ophthalmic complications, of whom seven had nonarteritic anterior ischemic ...

A rising star, Scott Eastwood is forging his own path with action-packed roles in Wrath of Man (2021), Dangerous (2021) and Fast X (2023). The son of Hollywood legend, Clint Eastwood, Scott may be ...

Eli Lilly has thinned its pipeline in two critical therapeutic areas, axing clinical-phase Alzheimer’s disease and obesity candidates ... a DACRA alongside tirzepatide, the active ingredient ...